Navigation Links
Cell transplants used to fend off Parkinson's symptoms

Doctors report they have had long-term success implanting cells into the brains of Parkinson's disease patients by passing a needle through the skull. Dr. Ray Watts, professor of //neurology at Emory University School of Medicine in Atlanta, told that patients had improved motor function - movement of their arms and legs - by up to 60% using this procedure.

Watts implanted retinal pigment epithelial cells, which are grown by the millions after being removed from human donor retinas. These particular cells produce dopamine, normally manufactured by neurons in the brain. Levels of dopamine steadily decrease as Parkinson's progresses. This is the first human intracerebral retinal cell implantation study in the world and we are encouraged by the results so far.

In the implantation procedure, doctors use brain imaging to select specific sites to deposit the cells. Then they pass needles through the forehead and top of the skull to implant the cells.

Patients showed improvement in tremor, stiffness, slow movement and balance, the most common motor functions affected by Parkinson's disease. In addition, half of the participants showed improvement of dyskinesia - involuntary movements that are a result of medications.
'"/>




Page: 1

Related medicine news :

1. Parasite infections linked to organ transplants
2. Bone marrow transplants for limbs
3. Cell transplants for stroke
4. More risks connected with live-donor liver transplants
5. Baltimore doctors perform three simultaneous kidney transplants
6. Skin cancer linked to usage of Drug Azathioprine in organ transplants
7. Innovative solution to help reduce the waiting times for kidney transplants
8. Islet cell transplants for Type 1 Diabetes
9. Partial-match cell transplants for kids with resistant leukemia
10. Flaws Reported in overview of US organ transplants
11. Evidence Links Protein Damage to Neurodegenerative diseases like Parkinsons and Alzheimers
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/27/2016)... ... 2016 , ... Two director-level employees of Horizon Blue Cross Blue Shield of ... 2016 honorees. The award recognizes businesswomen who excel in their fields and who ... the MLTSS (Managed Long-Term Services and Supports) Program at Horizon NJ Health and Theresa ...
(Date:5/27/2016)... ... May 27, 2016 , ... W.S. Badger Co. Inc ., the maker ... been recognized as one of the best small businesses for new dads by Fatherly, ... nine small businesses providing progressive benefits to new parents on the organization’s 2016 ...
(Date:5/27/2016)... ... May 27, 2016 , ... An influential resource amongst nurses ... time to shed lights on the variety of topics detailing why we appreciate nurses ... tackles why this career has gone from being in a major recession to one ...
(Date:5/27/2016)... York, NY (PRWEB) , ... May 27, 2016 , ... ... needing intervention to walk, the demand for a sustainable product to aid in the ... void and aid in the recovery of individuals with hemiplegia due to stroke. , ...
(Date:5/27/2016)... ... ... This campaign aims to provide a path to improved education and awareness ... change. , As nearly 795,000 Americans suffering from a new or recurrent stoke each ... an estimated 129,000 of these people dying from stroke, it’s become our nation’s fifth-leading ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... -- According to the 2016 report, a ... blood pressure monitoring system market growth. With aging, the ... respond to different pressure rates, leading to hypertension or ... cardiovascular disorders such as heart failure, stroke, coronary artery ... in prevalence each year. WHO estimates that 17 million ...
(Date:5/27/2016)... , May 27, 2016 ... innovative biopharma company focused on the highly lucrative ... a substantial pipeline of potential first-in-class or best-in-class ... are in development with strategic partners. HCM,s profitable ... fast-growing domestic market. We expect progress of the ...
(Date:5/27/2016)... TEL-AVIV, Israel , May 27, 2016 /PRNewswire/ ... KTOV), an innovative biopharmaceutical company focused on late-stage ... by Dexcel Pharma of pivotal batches ... Food and Drug Administration (FDA). This follows Kitov,s ... pivotal Phase III trial successfully met its primary ...
Breaking Medicine Technology: